Oncolytic viruses are genetically engineered or naturally occurring viruses that selectively infect and kill cancer cells. These viruses replicate within the tumor, causing cell lysis and stimulating an immune response against the cancer. An example is the FDA-approved T-VEC (talimogene laherparepvec) for melanoma, which has shown efficacy in shrinking tumors and promoting long-term immune memory.
